Recombinant Human His8-USP7 is a Ubiquitin-specific deconjugating enzyme. Reaction conditions will need to be optimized for each specific application. We recommend an initial Recombinant Human His8-USP7 concentration of 1-5 nM.
Source
Spodoptera frugiperda, Sf 21 (baculovirus)-derived human USP7 protein Met1 - Asn1102 with a N-terminal 8-His tag
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain.
Applications/Dilutions
Dilutions
Enzyme Activity
Theoretical MW
130 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Publications
Read Publications using E-519 in the following applications:
ubiquitin specific peptidase 7 (herpes virus-associated)
ubiquitin specific protease 7 (herpes virus-associated)
Ubiquitin thioesterase 7
Ubiquitin-specific-processing protease 7
USP7
Background
Ubiquitin Specific Peptidase 7 (USP7), also known as Herpes Virus-associated Ubiquitin Specific Protease (HAUSP), is a widely expressed deubiquitinating enzyme belonging to the peptidase C19 family (1). It has a predicted molecular weight of 130 kDa (2). Human USP7 is 1102 amino acids (aa) in length and shares 99% aa sequence identity with the mouse and rat orthologs (2,3). USP7 consists of a cysteine peptidase core (aa 208-560) that is flanked by an N-terminal TRAF-like domain (aa 50-205) and two C-terminal protease-resistant domains (aa 622-801 and 885-1061) (2,3). USP7 can be phosphorylated at Ser18 and Ser963 and ubiquitinated at Lys869 (2,4). USP7 was initially identified as a p53-interacting protein that deubiquitinates p53, thereby stabilizing the protein and inducing p53-dependent cell growth arrest and apoptosis (5). USP7 also targets the p53 regulatory proteins MDM2, MDMX, and Daxx, the epigenetic regulator Histone 2B, and the transcription factor FoxO4 (4,6-10). Additionally, USP7 interacts with the HSV-1 immediate early protein ICP0, contributing to the stabilization and transactivation capability of ICP0 during HSV-1 infection (1,11,12).
Everett, R.D. et al. (1997) EMBO J. 16:1519.
Fernández-Montalván, A. et al. (2007) FEBS J. 274:4256.
Holowaty, M.N. et al. (2003) J. Biol. Chem. 278:47753.
Khoronenkova, S.V. et al. (2012) Mol. Cell 45:801.
Li, M. et al. (2002) Nature 416:648.
Brooks, C.L. & W. Gu (2004) Cell Cycle 3:895.
Meulmeester, E. et al. (2005) Cell Cycle 4:1166.
Tanga, J. et al. (2010) Biochem. Biophys. Res. Commun. 393:542.
van der Knaap, J.A. et al. (2005) Mol. Cell 17:695.
van der Horst, A. et al. (2006) Nat. Cell Biol. 8:1043.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human His8-USP7 Protein, CF and receive a gift card or discount.